Voluntary industry pricing scheme under negotiation as science minister trails plan to boost clinical trials
Talks have started between the government, NHS and the pharmaceutical industry on a new medicines pricing scheme which it is hoped will help reinvigorate industry research in the UK.
The voluntary scheme on branded medicines is a non-binding agreement on how much the NHS pays for medicines, negotiated between the department of health, the NHS and the Association of the British Pharmaceutical Industry.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.